The goal of this clinical trial is to study the effects of DracoBelleTM Nu in different skin parameters associated with age. Volunteers will be asked to take either placebo of DracoBelleTM Nu capsules once a day by oral intake for a total period of 12 weeks. Several age-associated skin parameters (skin elasticity, firmness, fatigue, wrinkles, roughness, skin density, hydration, pigmentation and barrier effect) will be measured before the treatment and 4, 8 and 12 weeks after the first oral intake. Data of the placebo and DracoBelleTM Nu group will be analyzed to evaluate the effect of the product DracoBelleTM Nu in the selected age-associated skin parameters.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Skin elasticity will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin elasticity will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin firmness will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin firmness will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin fatigue will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin fatigue will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Wrinkles will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Wrinkles will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Roughness will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Roughness will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin density will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin density will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin hydration will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin hydration will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin barrier effect will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin barrier effect will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.
Skin pigmentation will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake.
Timeframe: Skin pigmentation will be measured before treatment (D0) and at week 4, week 8, and week 12 after the first oral intake of the product.